Formycon AG
Pharmaceutical composition of an anti-VEGF antibody

Last updated:

Abstract:

The present invention relates to liquid pharmaceutical formulations for intravitreal injection of an anti-VEGF antibody which does not contain saccharides for use in the treatment of age-related macular degeneration.

Status:
Grant
Type:

Utility

Filling date:

13 Nov 2014

Issue date:

25 Feb 2020